This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Feb;61(2):267-73.

doi: 10.1016/s0090-4295(02)02371-3.

Benign prostatic hyperplasia: a progressive disease of aging men

Mark Emberton¹, Gerald L Andriole, Jean de la Rosette, Bob Djavan, Klaus Hoefner, Remigio Vela Navarrete, Jorgen Nordling, Claus Roehrborn, Claude Schulman, Pierre Teillac, Andrea Tubaro, J Curtis Nickel

Affiliations

PMID: 12597928
DOI: 10.1016/s0090-4295(02)02371-3

Review

Benign prostatic hyperplasia: a progressive disease of aging men

Mark Emberton et al. Urology. 2003 Feb.

. 2003 Feb;61(2):267-73.

doi: 10.1016/s0090-4295(02)02371-3.

Authors

Mark Emberton¹, Gerald L Andriole, Jean de la Rosette, Bob Djavan, Klaus Hoefner, Remigio Vela Navarrete, Jorgen Nordling, Claus Roehrborn, Claude Schulman, Pierre Teillac, Andrea Tubaro, J Curtis Nickel

Affiliation

¹ Institute of Urology and Nephrology, University College, London, United Kingdom.

PMID: 12597928
DOI: 10.1016/s0090-4295(02)02371-3

No abstract available

PubMed Disclaimer

Similar articles

Prevention of benign prostatic hyperplasia disease.
Marks LS, Roehrborn CG, Andriole GL. Marks LS, et al. J Urol. 2006 Oct;176(4 Pt 1):1299-306. doi: 10.1016/j.juro.2006.06.022. J Urol. 2006. PMID: 16952616 Review.
Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia.
Jonas U, Höfner K. Jonas U, et al. J Urol. 1996 Sep;156(3):1040-1. doi: 10.1016/s0022-5347(01)65695-7. J Urol. 1996. PMID: 8709303 No abstract available.
Benign prostatic hyperplasia and prostate-specific antigen.
Pejčić T, Aćimović M, Džamić Z, Radovanović M, Hadži-Djokić J. Pejčić T, et al. Vojnosanit Pregl. 2015 May;72(5):447-53. Vojnosanit Pregl. 2015. PMID: 26165054 Review. No abstract available.
[Chronobiology of the benign growth of the prostate gland].
Ruiz de Burgos y Moreno JE. Ruiz de Burgos y Moreno JE. An R Acad Nac Med (Madr). 1990;107(2):223-49. An R Acad Nac Med (Madr). 1990. PMID: 1708213 Review. Spanish. No abstract available.
Prostate specific antigen and benign prostatic hyperplasia.
Laguna P, Alivizatos G. Laguna P, et al. Curr Opin Urol. 2000 Jan;10(1):3-8. doi: 10.1097/00042307-200001000-00002. Curr Opin Urol. 2000. PMID: 10650506 Review.

See all similar articles

Cited by

Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials.
Zhou Z, Cui Y, Wu J, Jin H. Zhou Z, et al. Exp Ther Med. 2020 Aug;20(2):1566-1574. doi: 10.3892/etm.2020.8851. Epub 2020 Jun 10. Exp Ther Med. 2020. PMID: 32742388 Free PMC article.
Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study.
El-Adawy MS, Abdelaziz AY, Salem A, Ela WA, Moussa AS, Ibrahim R, Zanaty F, Abdelhamid MH, Aldaqadossi H, Ragheb AM, Shaker HA, Kotb S. El-Adawy MS, et al. Urol Ann. 2020 Jul-Sep;12(3):271-275. doi: 10.4103/UA.UA_91_19. Epub 2020 Jul 17. Urol Ann. 2020. PMID: 33100754 Free PMC article.
The economic impact of delaying 5-alpha reductase inhibitor therapy in men receiving treatment for symptomatic benign prostatic hyperplasia.
Naslund M, Eaddy MT, Hogue SL, Kruep EJ, Shah MB. Naslund M, et al. Am Health Drug Benefits. 2011 May;4(3):155-62. Am Health Drug Benefits. 2011. PMID: 25126348 Free PMC article.
Comparison of clinical trials with finasteride and dutasteride.
Nickel JC. Nickel JC. Rev Urol. 2004;6 Suppl 9(Suppl 9):S31-9. Rev Urol. 2004. PMID: 16985923 Free PMC article.
Transurethral plasmakinetic resection versus enucleation for benign prostatic hyperplasia: comparison of intraoperative safety profiles based on endoscopic surgical monitoring system.
Jin Q, Yang EG, Zhang YX, Mi J, Dong ZL, Yang L, Tian JQ, Wang J, Wang ZP. Jin Q, et al. BMC Urol. 2022 Apr 19;22(1):65. doi: 10.1186/s12894-022-01014-7. BMC Urol. 2022. PMID: 35439982 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information